Connect your AI

OS Therapies OSTX Repayment Of Shareholder Loan

Other financials

Income statement

Operating income-$10.2M-103%

Net income-$10.4M-168%

EPS (diluted)-$0.27-50.0%

Balance sheet

Cash & equivalents$917.6K-69.1%

Total debt$20.0M—

Total equity-$10.8M-159%

Total assets$7.3M+71.7%

Cash flow

Operating cash flow-$4.6M-32.6%

CapEx$316.4K—

Free cash flow-$3.7M—

Valuation

Market cap$84.62M+65.5%

Enterprise value$103.7M—

Returns & leverage

Return on equity470%—

Debt / equity-1.8×—

Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept osti:RepaymentOfShareholderLoan.

The official record: OS Therapies’s 10-Q, filed May 18, 2026, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's repayment of shareholder loan.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is OS Therapies's repayment of shareholder loan?: OS Therapies (OSTX) reported repayment of shareholder loan of $23.64K in Q1 2025.